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Abstract: Background: Age, gender and systemic diseases all influence 
cardiac function and remodelling. In cats, age and gender associated 
myocardial remodelling and the effect of systemic diseases on the 
myocardium have so far not been studied. The aim of the study was 
therefore to investigate whether relevant cytokines and extracellular 
matrix (ECM) remodelling enzymes are expressed in the myocardium of cats 
with non-cardiac diseases and whether transcription levels are influenced 
by age and gender. 
Methods: The study was performed on myocardial samples from 26 cats aged 
between 2 and 19 years that had died with non-cardiac diseases. Seventeen 
cats were female (2 entire), nine were male (1 entire). Of these, nine 
cats were diagnosed with diseases unlikely to affect the myocardium 
(control cats). The remaining 17 cats suffered from diseases with likely 
systemic effects. All hearts were assessed for any pathological changes, 
and the myocardium was analysed for interleukin (IL)-1, -2, -4, -6, -18, 
tumour necrosis factor (TNF)-α, interferon (IFN)-γ, transforming growth 
factor (TGF)-β, matrix metalloproteinase (MMP)-2, -3, -13, tissue 
inhibitor of MMP (TIMP)-1, -2 and -3 transcription using quantitative RT-
PCR assays.  
Results: Despite the absence of any histological evidence of myocardial 
damage, inflammation and fibrosis, the myocardium of all cats was found 
to constitutively transcribe cytokines and ECM remodelling enzymes, with 
generally higher mRNA concentrations in atria than in ventricles. Young 
and male cats exhibited higher transcription levels throughout the 
myocardium in comparison to older and female cats. Furthermore, age-
associated transcription pattern differed between male and female cats.  
Conclusion: The constitutive transcription of ECM remodelling enzymes 
suggests continuous myocardial remodelling throughout the entire life of 
a cat. The myocardium of young and male cats appears to be in a pro-
inflammatory state, whereas in older and female cats the myocardium 
exhibits a reduced inflammatory reaction to systemic disease. Age-
associated cardiac remodelling seems to be influenced by non-hormonal 
factors in male and female cats. 
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4. Similarly, the figures, while commendably detailed with their multitude of p-values and symbols, are too 
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that they readily support the conclusions should be found. 
All figures were changed. 
5. In relation to the amount of data provided and their significance, both introduction and discussion section 
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Abstract 
Background:Age, genderand systemic diseases all influence cardiac function and 
remodelling.In cats, age and genderassociated myocardial remodelling and the effect of 
systemic diseases on the myocardium have so far not been studied. The aim of the study was 
therefore to investigate whetherrelevant cytokines and extracellular matrix (ECM) 
remodellingenzymesare expressed in the myocardium of cats with non-cardiac diseasesand 
whether transcription levels are influenced by age and gender. 
Methods:The study was performed on myocardial samples from 26 cats aged between 2 and 
19 years that had died with non-cardiac diseases. Seventeen cats were female (2 entire), nine 
were male (1 entire). Of these, nine cats were diagnosed with diseases unlikely to affect the 
myocardium (control cats). The remaining 17 cats suffered from diseases with likely systemic 
effects.All hearts were assessed for any pathological changes, and the myocardium was 
analysed for interleukin (IL)-1, -2, -4, -6, -18, tumour necrosis factor (TNF)-α, interferon 
(IFN)-γ, transforming growth factor (TGF)-β, matrix metalloproteinase (MMP)-2, -3, -13, 
tissue inhibitor of MMP (TIMP)-1, -2 and -3 transcription using quantitative RT-PCR assays.  
Results:Despite the absence of any histological evidence of myocardial damage,inflammation 
and fibrosis, the myocardium of all cats was found to constitutively transcribe cytokines and 
ECM remodelling enzymes, with generally higher mRNA concentrations in atria than in 
ventricles.Young and male cats exhibited higher transcription levels throughout the 
myocardium in comparison to older and female cats. Furthermore, age-associated 
transcription pattern differed between male and female cats. 
Conclusion:The constitutive transcription of ECM remodellingenzymes suggests continuous 
myocardial remodelling throughout the entire life of a cat. The myocardium of young and 
malecats appears to be in a pro-inflammatory state, whereas in older and female cats the 
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myocardium exhibits a reduced inflammatory reaction to systemic disease.Age-associated 
cardiac remodelling seems to be influenced bynon-hormonal factors inmale and female cats. 
 
Highlights 
 Myocardial cytokine, MMP and TIMP transcription varies with age and gender. 
 Age-dependent myocardial transcription differs in neutered male and female cats. 
 The myocardium of young and male cats is in a pro-inflammatory state. 
 Hearts of old and female cats show a reduced inflammatory reaction. 
 Cytokine and ECM remodelling enzyme transcription differs in atria and ventricles. 
 
 
Keywords (up to 6): myocardium; cytokine transcription; cardiac remodelling; age; 
extracellular matrix; MMP and TIMP expression. 
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1. Introduction 
In the human heart, ageing is characterised by progressive ventricular fibrosis and 
cardiomyocyte density, resulting in increased ventricular stiffness and diastolic 
dysfunction(Kitzman and Edwards, 1990). In the ageing human population heart failure with 
preserved ejection fraction is a frequent presentation. Gender differences are well known, 
with female species exhibiting favourable cardiac pathology (Chua et al., 2011; Pavon et al., 
2012).Furthermore, systemic diseases such as diabetes mellitus, renal diseases, hypertension, 
and obesity, are known comorbidities and contribute to impaired cardiac function (Ather et 
al., 2012). Similar presentations are seen in cats and dogs. Age associated increased 
ventricular stiffness is observed in pet animals (Santilli and Bussadori, 1998; Schober and 
Fuentes, 2001; Saunders, 2012), retrospective studies suggest a male predisposition 
forhypertrophic cardiomyopathy in cats (Atkins et al., 1992; Abbott, 2010; Payne et al., 
2010)and older animals develop systemic diseases that are known heart failure comorbidities 
in human patients (Metzger and Rebar, 2012; Saunders, 2012).  
Increased ventricular stiffness is caused by imbalanced extracellular matrix (ECM) 
remodelling and ventricular fibrosis (Spinale, 2007). The composition of the ECM is 
regulated by enzymes, the matrix metalloproteinases (MMP), which degrade the ECM 
components, and their inhibitors, tissue inhibitors of MMP (TIMP-1 to -4), which indirectly 
lead to ECM deposition(Vanhoutte and Heymans, 2010). Matrix metalloproteinase and TIMP 
imbalance and ECM degradation and deposition are associated withcardiac diseases and 
dysfunction (Spinale, 2007), but onlylittle is known about their role in age related cardiac 
changes. Mouse models ofageingexhibit varying MMP, TIMP and transforming growth 
factor (TGF)-β mRNA and protein production (Brooks and Conrad, 2000; Lindsey et al., 
2005; Tian et al., 2007; Kandalam et al., 2010; Wang et al., 2010; Givvimani et al., 2013; 
Uchinaka et al., 2014).  
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Cytokines play an important role in the activation of MMPs and TIMPs. They 
contribute to the regulation of inflammatory responses and are elevated in cardiac and 
systemic diseases (Hedayat et al., 2010; Fonfara et al., 2012;Fonfara et al., 2013a). In 
particular interleukin (IL)-6 and tumour necrosis factor (TNF)-α are linked to ageing 
processes and were found to be elevated in patients with loss of muscle mass and cachexia 
(Morley and Baumgartner, 2004; Walston et al., 2009). However, their main role during 
ageing is not yetclear(Maggio et al., 2006).  
No studies exist investigating the influence of age or gender on the myocardium in cats. 
Gaining knowledge of the myocardial ageing and remodelling processes in cats is of 
particular interest, not only because the systemic diseases that often affect ageing cats are 
similar to known human comorbidities (i.e. diabetes mellitus, renal diseases, systemic 
hypertension), but also because cats are commonly neutered, which allows the investigation 
of non-hormonal gender associated cardiac remodelling. 
The objective of the present study was to investigate the constitutive, i.e. non-cardiac 
disease associated transcription of a range of cytokines and ECM remodelling enzymes 
known to be relevant for cardiac remodelling in other species, in different cardiac regions and 
in catsof different gender and age. A proportion of cats had systemic diseases that potentially 
affected cardiac function or resulted in a systemic inflammatory response. The transcription 
patterns of these cats were therefore compared to the baseline expression of cats with diseases 
unlikely to affect the heart. 
 
2. Material and methods 
2.1.Animals and tissues 
Twenty six cats were included in the study. Cats were patients that had been presented 
at the Universities of Helsinki and Bristol without clinical evidence of cardiac disease and 
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had been euthanised upon owner’s request due to poor prognosis, impaired quality of life or 
financial constraints. Informed consent was obtained from owners prior to inclusion into the 
study and cats were assigned arbitrary numbers as identifiers. Institutional ethical approval 
was obtained. 
From each cat, thesignalement including breed, sex, age, weight and body condition 
score (BCS) was recorded.The heart was removed within one hour after death and grossly 
examined which confirmed the absence of any apparent cardiac disease. Myocardial samples 
from the interventricular septum, right atrium and ventricle, and left atrium and ventricle 
were collected for RNA extraction and stored in RNA stabilising solution 
(RNAlater;Ambion, Life Technologies, Paisley, UK) at -20°C until analysed. Hearts were 
subsequently fixed in 10% formalin and samples from the same sites as those for RNA 
extraction were prepared and routinely paraffin wax embedded for histological examination. 
Sections (3-5 μm thick) were prepared and stained with haematoxylin-eosin (HE).  
Twenty three cats subsequently underwent full necropsy to identify any relevant disease 
conditions. Samples were collected from all major organs as well as any gross abnormalities, 
fixed in 10% formalin and routinely paraffin wax embedded for histological examinationof 
HE stained sections.For the remaining three cats (all from group “control cats”) owners did 
not give consent for a full necropsy and only dissection and histological examination of the 
heart was permitted. 
Based on the clinical and pathological findings, cats with diseases unlikely to have an 
effect on cardiac function and/or unlikely to have systemic effects, such as the systemic 
release of cytokines, that could have induced cytokine, MMP and/or TIMP production in the 
myocardium, were considered as control cats (group “control cats”); all remaining cats were 
allocated to group “systemic diseases”, implying that they suffered from conditions with 
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potential systemic effects, which might have influenced myocardial transcription processes 
(Fonfara et al., 2013a, b).  
 
2.2.RNA extraction 
After removal from RNAlater, total RNA was extracted from the myocardial samples 
using a commercially available kit (Qiagen RNeasy Plus Universal mini Kit, Manchester, 
UK) according to the manufacturer’s protocol. An initial step was added in which the tissue 
was placed in liquid nitrogen; the frozen tissue was then transferred into 900 μL lysis reagent 
and ground thoroughly with a tissue pestle grinder. An on-column DNA digestion step was 
included. Final elution of the total RNA was performed using 30 μL of RNase-free water and 
repeated to maximize the amount of eluted RNA. The total RNA concentration of each 
sample was determined with a spectrophotometer.  
 
2.3.Real time PCR 
cDNA was synthesised from 300 ng total RNA using the I Skript cDNA Synthesis Kit 
(Biorad, Hertfordshire, UK) according to the manufacturer’s protocol and stored at -80°C 
until use in the quantitative PCR. For the feline housekeeping gene GAPDH, as well as feline 
IL-1, -6, -18, TNF-α and TGF-β1,primers of previously published sequences were used 
(Kipar et al., 2001; Van Nguyen et al., 2006; Taglinger et al., 2008). Primers for feline IL-2, 
IL-4, IFN-γ, MMP-2, -3, 13, TIMP-1, -2 and -3 were designed using Primer Express software 
(Applied Biosystems, Life Technologies), and BLAST searches performed to confirm gene 
specificity. Primer sequences are shown in Table 1. Primers were synthesised by Eurogentec 
(Hamphsire, UK). Primers were validated using a standard curve of eight serial dilutions and 
primer efficiencies were between 94% and 99%. PCR was performed according to standard 
protocols.Aliquots (1 μL) of cDNA were amplified in duplicates by PCR in 20 μL reaction 
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volumes on a real time Stratagene 3500(Applied Biosystems, Life Technologies) using 
Maxima SYBRGreen qPCR Master Mix (Fermentas, Cheshire, UK). Each assay well had a 
20 μL reaction volume consisting of 12.5 μL SYBR Green PCR mastermix, each of 400 nM 
forward and reverse primers, and 1 μL of sample cDNA (templates) or water (negative 
controls). The amplification was performed according to standard protocols, with 2 min at 
50°C, 10 min at 95°C, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The PCR 
was followed by a dissociation programmewith 1 min at 95°C, succeeded by 41 cycles during 
which the temperature was increased by 1°C at each cycle, starting at 55°C and ending at 
95°C. All PCR reactions exhibited one well-defined melting curve peak. Relative expression 
levels were normalised to GAPDH and calculated using the 2
-ΔΔCt
 method (Livak and 
Schmittgen, 2001). 
 
Table 1 
Primer sequences used for quantitative PCR. 
 
Primer  Sequence (5’-3’) 
IL-2 
Forward CTGCTTCAAGCTCTACAAAGGAAAC 
Reverse CTCCATTCAAAAGCAACCGTAAA 
IL-4 
Forward TCGTCCACGGCCAGAACT 
Reverse TTTCTCGCTGTGAGGATGTTCA 
IFN-γ 
Forward ATGATGACCAGCGCATTCAA 
Reverse TTTACTGGAGCTGGTATTTAACAACTTATC 
MMP-2 
Forward TGGAGAGGCGGACATCATG 
Reverse CCCGTCCTTGCCATCAAA 
MMP-3 
Forward GTTCTGGGCCATGAGAGGAA 
Reverse GGAAAACCCAGGGTGTGGAT 
MMP-13 
Forward GACCCTCGACGCCATCAC 
Reverse GCAGGCGCCAGAAGAATCT 
TIMP-1 
Forward GATACTTGCACAGGTCCCAGAAC 
Reverse TCCGTCCCGCAGGTTTC 
TIMP-2 
Forward CTCCGGATGAATGTCTCTGGAT 
Reverse GCAGAAGAACTTGGCCTGATG 
TIMP-3 
Forward CAACAAATACCAGTACCTGCTGACA 
Reverse GGTCCCACCTCTCCACAAAGT 
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IL: interleukin, IFN: interferon, MMP: matrix metalloproteinase, TIMP: tissue inhibitor of 
matrix metalloproteinase. 
 
 
2.4.Statistical analysis 
For the statistical analysis of the PCR results, SPSS was used. Basic descriptive 
statistics were calculated for the parameters recorded and analysed. Age and weight were 
normally distributed. Other variables were log transformed to improve normality and the 
model assumptions necessary for parametric analysis. 
No difference in transcriptions waspresent between the right and left atrium (data not 
shown), which were subsequently combined as “atrial samples”. The same was true for the 
three ventricular localisations (right and left ventricle and interventricular septum; data not 
shown) and these were combined as“ventricular samples”. These combined sample groups 
were subsequently used for the comparison of localisations.  
Constitutive transcription was assessed in group “control cats”. Subsequently, to assess 
the effect of non-cardiac diseases with potential systemic effects, all group “systemic 
diseases” animals were compared with group “control cats”. Cardiac regions,groups and 
genderwere compared using 1-way ANOVA andunpaired t-tests as appropriate. Linear 
regression analysis was used to explore the relationship between the markers investigated and 
age and body weight. Results are displayed as mean and standard deviation. Statistical 
significance was defined as P < 0.05. 
 
3. Results 
3.1. Study population 
Seventeen cats were female (2 entire), nine were male (1 entire). The age of the entire 
population ranged from 2 to 19 years with a mean of 9 years ± 6. No significant difference 
for age, weight or BCS was present between male and female cats (data not shown). Nine 
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cats (group “control cats”) had been euthanised due to behavioural abnormalities or because 
they exhibited local disease processes that the owners decided not to treat due to financial 
constraints (Table 2).This entire group subsequently served as control for the group “systemic 
diseases” cats with diseases that were considered to have potential systemic effects including, 
potentially, the induction of cytokine and ECM enzyme production in the myocardium (Table 
2).No significant difference between groups was observed for age, weight and BCS (data not 
shown).  
 
Table 2 
Breed, sex, age, weight, body condition score (BCS) and main diagnosis of cats included in 
group “control cats”(cats with diseases unlikely to have systemic effects or influence cardiac 
function) andgroup “systemic diseases”(cats with diseases likely to have systemic effects or 
an influence on cardiac function).  
 
Group Breed Sex 
Age 
(years) 
Weight 
(kg) 
BCS 
(/5) 
Diagnosis 
Control 
cats 
DSH FN 2 4.3 3 Oesophageal stricture 
DSH FN 2 4.5 3 Nasal polyp 
DSH FN 3 5 3 
Discus prolaps, no 
improvement post-surgery 
DSH FN 9 5.8 4 Behaviour abnormalities 
DLH FN 10 4 3 Behaviour abnormalities  
DSH FN 10 3 2 Behaviour abnormalities 
DSH FN 14 1.7 2 Nasal osteosarcoma 
DSH M 14 4.6 3 
Age-related non-specific 
changes 
DSH FN 19 3.3 2 
Gastrointestinal stromal 
tumour 
Systemic 
diseases 
DSH F 2 3.5 3 
Non-suppurative 
meningoencephalitis, chronic 
interstitial pancreatitis, 
interstitial nephritis, mild 
pericholangitis 
BSH MN 3 n.r. 3 
Lymphocytic 
cholangiohepatitis 
DSH FN 4.5 3 2 Pulmonary adenocarcinoma 
DSH MN 6 6.1 4 Astrocytoma 
Devon 
Rex 
MN 7 n.r. n.r. 
Lymphoplasmacytichepatitis 
DSH MN 8 6 4 
Pancreatic islet amyloidosis, 
one endstage kidney 
Siamese FN 8 n.r. 2 Mast cell tumour 
DSH MN 9 4 2 
Intestinallymphoma(with 
involvement of liver and lung) 
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Oriental FN 10 2.7 3 
Mammary adenocarcinoma 
with lung metastases 
DSH MN 10 4 2 Multicentric lymphoma 
DSH FN 12 3.9 2 
Diabetes mellitus-associated 
pancreatic and hepatic 
changes  
DSH MN 13 6 3 
Pyogranulomatous nephritis 
(FIP excluded) 
DSH MN 13 4.4 3 
Necrotising neutrophilic 
colitis with purulent 
lymphadenitis  
DSH F 14 3 2 
Marked chronic 
cholangiohepatitis, mild 
chronic interstitial pancreatitis 
and chronic enteritis 
DSH FN 15 2.9 2 
Adenocarcinoma lung, 
metastases in kidney, brain, 
pancreas 
DSH FN 18 3.8 3 Chronic cystitis 
DSH FN 19 2.7 3 
End stage kidney, eosinophilic 
syndrome, chronic pancreatitis 
BCS: body condition score, BSH: British short-hair cat, DLH: domestic long-hair cat, DSH: 
domestic short-hair cat, F: female, FN: female neutered, kg: kilogram, M: male, MN: male 
neutered, n.r.: not recorded. 
 
3.2. Cytokines, MMPs and TIMPs are constitutively transcribed in the feline myocardium, 
with higher transcription levels in atria. 
All examined cytokines, MMPs and TIMPs were found to be transcribed, with some 
variation in frequency and some degree of intra- and interindividualquantitative variation. IL-
1, IL-2, IL-4, IL-18, IFN-γ, TGF-β, MMP-2, MMP-3, MMP-13, TIMP-2 and TIMP-3 mRNA 
was detected in all samples, i.e. both in atria and ventricles of all cats regardless of age, sex 
and disease, whereas IL-6, TNF-α, and TIMP-1 were expressed in 94%, 89%, and 81%, 
respectively.Among the cytokines, IL-18 and TGF-β exhibitedthe overall highest 
transcription levels, followed by IFN-γ, IL-2, IL-4, IL-1, IL-6, and TNF-α (Figure 1A). 
Among the ECM remodelling enzymes, TIMP-2 mRNA levels were highest, followed by 
TIMP-3, MMP-2, -3, -13 and TIMP-1 (Figure 1B). An assessment of individual cats (and 
diseases) did not identify any cases with overall higher cytokine, MMP or TIMP transcription 
levels; also, there was no evidence of disease associated expression patterns. 
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A comparison between atria and ventriclesshowed that transcription levels of all 
markers were generally significantly higher in the atria when the entire study population 
(p<0.001, Figure 1A, B) or the cats with systemic, non-cardiac diseases (group “systemic 
diseases”) were examined. In the control cats (group “control cats”), this applied to most 
markers.  
 
Fig. 1A 
 
Fig. 1B 
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Fig. 1A, B.Relative mRNA expression of (A) IL-1, IL-2, IL-4, IL-6, TNF-α, IFN-γ, TGF-ß, 
and (B) MMP-2, MMP-3, MMP-13, TIMP-1, TIMP-2 and TIMP-3 comparing atria (A) 
ventricular (V) samples. Transcription levels of all markers were significantly higher in atria 
than ventricular samples (p<0.001). Error bars, bars represent 95% confidence interval for 
mean. 
 
 
3.3. The myocardium exhibits age- and gender-associated quantitative differences in the 
expression of cytokines, MMPs and TIMPs 
Age was negatively correlated with myocardial transcription for IL-1 (p=0.008), IL-2 
(p<0.001), IL-4 (p<0.001), IL-6 (p=0.013), IFN-γ (p=0.034), MMP-3 (p=0.004). A positive 
correlation was present with TGF-β (p=0.019). This applied for atrial and ventricular samples 
for IL-4 (p=0.01 and p=0.003, respectively), the correlation for the other markers was only 
apparent in the ventricles (IL-1 p=0.019, IL-2 p<0.001, IL-6 p=0.018, IFN-γ p=0.025, TGF-β 
p=0.001, MMP-3: p=0.008; Figure 2 A-D).  
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Fig. 2B 
 
Fig. 2C 
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Fig. 2D 
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Fig. 2 A-D. Scatterplots of age and relative IL-1 (A), IL-4 (B), MMP-3 (C) and TGF-β (D) 
mRNA expression in atria (A) and ventricles (V). A significant association of age and mRNA 
levels was present for atria and ventricular samples for A.IL-4 (p=0.01 and p=0.003, 
respectively) and for ventricular samples for B.IL-1 (p=0.019), C.MMP-3 (p=0.008) and 
D.TGF-β (p=0.001).  
 
Comparing transcription levels of male and female cats showed significantly lower 
levels for IL-1 (p<0.001), IL-2 (p=0.002), IL-4 (p<0.001), IL-6 (p<0.001), IL-18 (p<0.001), 
TNF-α (p<0.001), MMP-3 (p=0.001), TIMP-1 (p<0.001) and TIMP-2 (p=0.006) in the entire 
myocardiumof female cats (Figure 3A, B). As for the entire cat population, both genders 
exhibitedgenerally higher transcription levels in the atria.  
For female cats a negative association of age and myocardialIL-1 (p<0.001), IL-2 
(p<0.001), IL-4 (p<0.001), IL-6 (p=0.001), IFN-γ (p=0.002), MMP-3 (p<0.001), and TIMP-2 
(p=0.021) mRNA expression was observed, for male cats this applied for IL-6 (p=0.003), 
MMP-2 (p=0.034) and TIMP-1 (p=0.02). 
 
Fig. 3A 
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Fig. 3B 
 
Fig. 3A, B. Relative myocardial mRNA expression of (A) IL-1, IL-2, IL-4, IL-6, TNF-α, 
IFN-γ, TGF-ß, and (B) MMP-2, MMP-3, MMP-13, TIMP-1, TIMP-2 and TIMP-3 comparing 
male (M) and female (F) cats. Significantly lower IL-1 (p<0.001), IL-2 (p=0.002), IL-4 
(p<0.001), IL-6 (p<0.001), IL-18 (p<0.001), TNF-α (p<0.001), MMP-3 (p=0.001), TIMP-1 
(p<0.001) and TIMP-2 (p=0.006) mRNA levels were present in the female myocardium. 
Error bars, bars represent 95% confidence interval for mean. 
 
 
3.4. Non-cardiac systemic diseases are associated with increased myocardial cytokine, MMP 
and TIMP transcription 
A comparison of the overall transcription levels of all markers in control cats and cats 
with systemic diseases showed significantly higher levels for IL-1 (p=0.001), IL-4 (p=0.005), 
IL-6 (p=0.002), IL-18 (p<0.001), TNF-α (p=0.005), MMP-13 (p=0.006), TIMP-1 (p=0.04), 
TIMP-2 (p=0.019) in cats with non-cardiac systemic diseases (Figure 4A, B). For IL-1, IL-6, 
IL-18 and TIMP-2 this applied to both atria and ventricles, whereas it applied to atria only for 
IL-4andMMP-13 and to ventricles only for TNF-α. For IL-2, IFN-γ, TGF-ß, MMP-2 and -3 
as well as TIMP-1 and -3, differences were not significant. 
TIMP3TIMP2TIMP1MMP13MMP3MMP2
FMFMFMFMFMFM
3
2
1
0
-1
-2
-3
R
e
la
tiv
e
 M
M
P
 a
n
d
 T
IM
P
 e
x
p
re
ss
io
n
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
18 
 
 
Fig. 4A 
 
Fig. 4B 
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Fig. 3A, B. Relative myocardial mRNA expression of (A) IL-1, IL-2, IL-4, IL-6, TNF-α, 
IFN-γ, TGF-ß, and (B) MMP-2, MMP-3, MMP-13, TIMP-1, TIMP-2 and TIMP-3 comparing 
“control cats” (Con.) and cats with non-cardiac “systemic diseases” (Sys.). Significantly 
higher mRNA levels for IL-1 (p=0.001), IL-4 (p=0.005), IL-6 (p=0.002), IL-18 (p<0.001), 
TNF-α (p=0.005), MMP-13 (p=0.006), TIMP-1 (p=0.04), TIMP-2 (p=0.019)were presentin 
cats with non-cardiac systemic diseases.Error bars, bars represent 95% confidence interval 
for mean. 
 
4. Discussion 
The present study assessed the transcription of cytokines and ECM remodelling 
enzymes in the feline heart and provides valuable basic information on myocardial function 
and reaction patterns. Our study shows that the myocardium of cats does indeed 
constitutively transcribe not only inflammatory and pro-fibrotic cytokines, i.e. IL-1, -2, -4, -6, 
-18, IFN-γ, TNF-α and TGF-β, but also ECM remodelling enzymes (MMP-2, -3, 13, TIMP-1, 
-2 and -3), with generally higher mRNA concentrations in atria than in ventricles. These 
results are in line not only with our previous findings in dogs (Fonfara et al., 2013a, b), where 
we could also confirm protein expression and identified the cardiomyocytes as the source of 
these markers (own observations), but also with a recent immunohistological study 
undertaken on cats (Aupperle et al., 2011). It suggests continuous remodelling of the feline 
myocardium at any age. 
A younger age and male gender wereassociated with higher myocardial cytokine 
transcription. Furthermore, the age-associated myocardial reaction pattern differed between 
male and female cats.Considering that the majority of cats were neutered, other than 
hormonal factors seem to influence cardiac inflammation and remodelling (Chua et al., 2011; 
Pavon et al., 2012). In the absence of androgens as cause forcardiac inflammation, the higher 
myocardial levels of inflammatory and immune modulatory cytokines in the male cats might 
be associated with anappropriate myocardial response to the systemic diseases present in 
most cats, whereas the myocardium of female cats fails to develop a reactive response(Fang 
et al., 2007; Chen and Frangogiannis, 2010;Chua et al., 2011; Pavon et al., 2012). Similarly, a 
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younger age was associated with an increased transcription of inflammatory and immune 
modulatory cytokines. Several studies have confirmed the involvement of IL-1, IL-6, and IL-
18 in myocardial inflammation, fibroblast proliferation, and increased collagen 
production(Colston et al., 2007; Chen et al., 2008; Yu et al., 2009; Hedayat et al., 2010; 
Tamariz and Hare, 2010; Fix et al., 2011). However, these cytokines are also involved in 
myocardial repair, compensatory ventricular hypertrophy and myocardial adjustment to 
changing haemodynamics (Colston et al., 2007; Yu et al., 2009; Hedayat et al., 2010; Fix et 
al., 2011).It is therefore possible that the observed inflammatory response is of benefit and 
enables myocardial repair (Chen and Frangogiannis, 2010; Chua et al., 2011). On the other 
hand, an increased inflammatory potential might predispose to myocardial damage and 
fibrosis, and cardiac diseases, i.e. hypertrophic cardiomyopathy, are more frequently 
diagnosed in male than female cats(Atkins et al., 1992; Abbott, 2010; Payne et al., 2010). 
Whilst inflammatory cytokines reduced with age, TGF-β 
transcriptionincreasedsuggestinga profibrotic potential of the myocardium. In mouse models 
of ageing, increased TGF-β protein expression was seen in association with interstitial 
myocardial fibrosis and decreased ventricular compliance (Brooks and Conrad, 2000; Wang 
et al., 2010; Cai et al., 2012), andin cardiac diseases, TGF-β is known to be involved in the 
pathogenesis of cardiac remodelling and fibrosis (Khan and Sheppard, 2006; Dobaczewski et 
al., 2011).  
Interestingly, age associated myocardial marker transcription differed between both 
sexes. Femalecats exhibited a reduction of IL-1, IL-2, IL-4, IL-6, IFN-γ, MMP-3 and TIMP-2 
with age,in male cats this applied for IL-6, MMP-2 and TIMP-1.Conflicting results are 
reported for the role of immune modulatory cytokines in cardiac remodelling. In mouse 
models, Th2 induction resulted in reduced ventricular stiffness, and Th1 cells were involved 
in initiation of fibrosis and collagen crosslinking(Yu et al., 2005; 2010), whereasanother 
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study did detecta shift from Th1 to Th2 response in old mice in association with interstitial 
myocardial fibrosis (Cieslik et al., 2011). We observed a reduction of all three immune 
modulatory markers (IL-2, IL-4,IFN-γ)with age in thefemale cats, which might be consistent 
with a generally reduced myocardial inflammatory response, as suggested by thereduced 
transcriptionof IL-1 and IL-6.Aupperle and co-authors (2011) observed reduced TIMP-2 
expression in association with myocardial fibrosis in cats.In older sheep (> 8 years), rat and 
mouse models, higher myocardial MMP-2 and reduced TIMP-2 mRNA and protein 
expression, as well as cardiomyocyte hypertrophy and perivascular and interstitial fibrosis, 
imbalanced cardiac remodelling and impaired repair was observed (Kandalam et al., 2010; 
Wang et al., 2010; Horn et al., 2012; Givvimani et al., 2013). The age-associated reduced 
TIMP-2 and MMP-2 transcription in female and male cats, respectively,suggests therefore a 
pro-fibrotic potential and impaired repair of the female myocardium, and further supports a 
reactive male myocardium facilitating appropriate repair (Davis et al., 2007; Chen and 
Frangogiannis, 2010). 
Cats with diseases likely to have systemic effects showed overall higher myocardial 
transcription of IL-1, -6, -18 and TIMP-2, higher atrial transcription of IL-4 and MMP-13 and 
higher ventricular transcription for TNF-α than cats with diseases unlikely to have an effect 
on cardiac function. This suggests that systemic diseasescan induce and influence cardiac 
inflammation and remodelling, despite the lack of direct cardiac involvement in the disease 
and in the absence of cardiac histopathological changes. Similar observations have been 
reported for dogs (Fonfara et al., 2013a, b). Particular diseases, such as neoplasia, i.e. 
lymphoma, and inflammatory diseases have been shown to influence localised and circulating 
cytokine and MMP concentrations in dogs and cats (Van Nguyen et al., 2006; Janeczko et al., 
2008; Stich and DeClue, 2011; Arico et al., 2013; Aresu et al., 2014). Although these studies 
did not investigate the heart, it is not unlikely that these also influence the myocardial 
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transcription. In our study, we could not detect any potential disease associated myocardial 
transcription pattern, which would suggest a more general, i.e. non-specific and pro-
inflammatory effect on the heart as part of the general systemic effects of these non-cardiac 
diseases; however, further studies on larger animal cohorts would be required to thoroughly 
address this issue.  
Interestingly, significant age-associated differences were predominantlyseen in the 
ventricles, whereas diseases with likely systemic effects seem to influence transcription levels 
in both atria and ventricles. Age-associated remodelling might therefore predominantly affect 
the ventricles, which might be involved in the development of heart failure with preserved 
ejection fraction (Santilli and Bussadori, 1998; Saunders, 2012; Loffredo et al., 2014). In 
contrast, diseases with systemic effects seem to influence the myocardium in general. The 
former might be the basis for regional differences in myocardial remodellingand the 
development of cardiac dysfunction and arrhythmia in patients with systemic diseases, as 
previously reported for dogs (Brundel, 2005; Fonfara et al., 2013a, b).  
We are aware of the limitations of this study due to the small group sizes and the 
inhomogeneity of the groups, which all comprised diseased cats, though without any clinical 
and pathological evidence of cardiac disease. An influence on the detected transcription 
pattern in cats with disease conditions unlikely to affect the heart cannot be excluded 
completely. However, this is unlikely to be relevant, as differences in myocardial 
transcription between these cats and cats with diseases likely to have systemic effects were 
observed.We could not generate meaningful data on age-associated transcription patterns in 
control cats, since our control animal numbers were too low. Furthermore, a potential 
influence of diet and exercise was not considered in the cat population of our study. 
 
5. Conclusion 
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The results of the present study suggest age-and gender-associated differences in the 
type and degree of cardiac remodelling. The myocardium of male and younger cats appears 
to be in a more pro-inflammatory basic state, whereas in female andolder cats a reduction in 
the inflammatory responsiveness is suggested. Furthermore, genderdifferences in age-
associated cardiac transcription pattern were observed, despite the majority of cats being 
neutered. Further investigations are now needed to fully elucidate gender differences and the 
ageing processes of the feline myocardium, the myocardial reactivity to systemic non-cardiac 
diseases, and the potential association with cardiac diseases. 
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